Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine Kinase Receptors in Oncology
Jorge Esteban-Villarrubia, J.J. Soto Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8529-8529
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
Angel A Justiz-Vaillant, Bijay Raj Pandit, Chandrashekhar Unakal, et al.
Antibodies (2025) Vol. 14, Iss. 2, pp. 35-35
Open Access
Progression and Expansion of ALK Inhibitors Against NSCLC: A Dual Target Approach
Shreya Kumari, Mymoona Akhter, Ghanshyam Das Gupta, et al.
European Journal of Medicinal Chemistry (2025) Vol. 293, pp. 117722-117722
Closed Access
Molecular insights into diabetic wound healing: Focus on Wnt/β-catenin and MAPK/ERK signaling pathways
Shivam Pandey, Tushar Anshu, Krushna Ch Maharana, et al.
Cytokine (2025) Vol. 191, pp. 156957-156957
Closed Access
The NLRP3 Inflammasome Works as a Sensor for Detecting Hypoactivity of the Mitochondrial Src Family Kinases
Yuto Sekiguchi, Saya Takano, Takuya Noguchi, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 6, pp. 795-806
Closed Access | Times Cited: 9
Bone complications of cancer treatment
Nanxi Zhu, Hao Ni, Shengzhao Guo, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102828-102828
Closed Access | Times Cited: 3
Tyrosine kinases in nodal peripheral T-cell lymphomas
Pier Paolo Piccaluga, Chiara Cascianelli, Giorgio Inghirami
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Genetic Variants in the ABCB1 and ABCG2 Gene Drug Transporters Involved in Gefitinib-Associated Adverse Reaction: A Systematic Review and Meta-Analysis
Mariana Vieira Morau, Cecília Souto Seguin, Marília Berlofa Visacri, et al.
Genes (2024) Vol. 15, Iss. 5, pp. 591-591
Open Access | Times Cited: 2
Molecular pathways and therapeutic strategies in dermatofibrosarcoma protuberans (DFSP): unravelling the tumor's genetic landscape.
Harpreet Singh, Heena Bholaram Choudhary, Deepa S. Mandlik, et al.
PubMed (2024) Vol. 23, pp. 727-762
Closed Access | Times Cited: 2
A phosphatase-recruiting bispecific antibody-aptamer chimera for enhanced suppression of tumor growth
Wei Li, Weihua Lu, Zhen Liu
Chemical Communications (2023) Vol. 59, Iss. 43, pp. 6572-6575
Closed Access | Times Cited: 6
Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies
Sheng Sun, Jiqiu Qin, Wenhao Liao, et al.
Cardiovascular Toxicology (2023) Vol. 23, Iss. 7-8, pp. 233-254
Closed Access | Times Cited: 6
A review of emerging tyrosine kinase inhibitors as durable treatment of neovascular age-related macular degeneration
Nikhil Das, Sameer Chaurasia, Rishi P. Singh
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 3, pp. 203-211
Closed Access | Times Cited: 6
Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams
Massimo Serra, Davide Rubes, Sergio Schinelli, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4173-4173
Open Access | Times Cited: 5
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene
Javier Torres-Jiménez, Jorge Esteban-Villarrubia, Reyes Ferreiro-Monteagudo
Cancers (2022) Vol. 14, Iss. 15, pp. 3718-3718
Open Access | Times Cited: 8
Immunohistochemical and Molecular Genetic Analysis of Canine Digital Mast Cell Tumours
David Conrad, Alexandra Kehl, Tobias Müller, et al.
Animals (2023) Vol. 13, Iss. 10, pp. 1694-1694
Open Access | Times Cited: 4
Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams
Massimo Serra, Davide Rubes, Sergio Schinelli, et al.
(2023)
Open Access | Times Cited: 4
Analysis of CD74 Occurrence in Oncogenic Fusion Proteins
Jasmine Vargas, Georgios Pantouris
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15981-15981
Open Access | Times Cited: 4
Trackins (Trk-Targeting Drugs): A Novel Therapy for Different Diseases
George N. Chaldakov, Luigi Aloe, Stanislav Yanev, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 961-961
Open Access | Times Cited: 1
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential
Qi Yu, Shumin Deng, Kuan-Song Wang
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4172-4196
Closed Access | Times Cited: 1
Regulation of HNRNP family by post-translational modifications in cancer
B Li, Mingxin Wen, Fei Gao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Expression of Mutated BRAFV595E Kinase in Canine Carcinomas—An Immunohistochemical Study
Alexander Bartel, Heike Aupperle‐Lellbach, Alexandra Kehl, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 11, pp. 584-584
Open Access | Times Cited: 1
Design, synthesis, and antiproliferative activity of new 1,2,3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38403-38415
Open Access | Times Cited: 1
New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells
Eva Schaller, Andi Ma, Lisa Chiara Gosch, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2243-2243
Open Access | Times Cited: 9
Investigation of a Novel NTRK1 Variation Causing Congenital Insensitivity to Pain With Anhidrosis
Kai Yang, Yicheng Xu, Huaying Hu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8
Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy
João Figueira Scarini, Luccas Lavareze, Reydson Alcides de Lima‐Souza, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103863-103863
Closed Access | Times Cited: 6
The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer
Syam Mohan, Mohammed Ageeli Hakami, Hamad Ghaleb Dailah, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155016-155016
Closed Access | Times Cited: 3

Scroll to top